NCT06984302 A PREDICTIVE ALGORITHM IN AORTIC SURGERY
| NCT ID | NCT06984302 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Hemodynamic |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-06-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We will enroll patients scheduled for abdominal aortic aneurysm repair and divide in two groups; in the control group the hemodynamic optimization will be made based on standard cardiovascular parameters showed in the Hemosphere platform. In the interventional group the hemodynamic optimization will be made based on the hypotension prediction index.
Eligibility Criteria
Inclusion Criteria: * planned aortic surgery acceptance of written informed consent Exclusion Criteria: * body mass index \> 35 kg/m2 * atrial fibrillation * urgent surgery * end-stage renal disease * pregnancy * refusal of the consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06984302 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hemodynamic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06984302 currently recruiting?
Yes, NCT06984302 is actively recruiting participants. Contact the research team at andrea.russo@policlinicogemelli.it for enrollment information.
Where is the NCT06984302 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT06984302 clinical trial?
NCT06984302 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 80 participants.